235 related articles for article (PubMed ID: 10405747)
21. Early hepatocellular carcinoma: MR imaging.
Muramatsu Y; Nawano S; Takayasu K; Moriyama N; Yamada T; Yamasaki S; Hirohashi S
Radiology; 1991 Oct; 181(1):209-13. PubMed ID: 1653443
[TBL] [Abstract][Full Text] [Related]
22. Hypovascular hypointense nodules on hepatobiliary phase gadoxetic acid-enhanced MR images in patients with cirrhosis: potential of DW imaging in predicting progression to hypervascular HCC.
Kim YK; Lee WJ; Park MJ; Kim SH; Rhim H; Choi D
Radiology; 2012 Oct; 265(1):104-14. PubMed ID: 22891358
[TBL] [Abstract][Full Text] [Related]
23. Transplantation for hepatocellular carcinoma and cirrhosis: sensitivity of magnetic resonance imaging.
Krinsky GA; Lee VS; Theise ND; Weinreb JC; Morgan GR; Diflo T; John D; Teperman LW; Goldenberg AS
Liver Transpl; 2002 Dec; 8(12):1156-64. PubMed ID: 12474156
[TBL] [Abstract][Full Text] [Related]
24. Hepatocellular carcinoma in the cirrhotic liver: gadolinium-enhanced 3D T1-weighted MR imaging as a stand-alone sequence for diagnosis.
Hecht EM; Holland AE; Israel GM; Hahn WY; Kim DC; West AB; Babb JS; Taouli B; Lee VS; Krinsky GA
Radiology; 2006 May; 239(2):438-47. PubMed ID: 16641353
[TBL] [Abstract][Full Text] [Related]
25. Cirrhotic nodules: association between MR imaging signal intensity and intranodular blood supply.
Shinmura R; Matsui O; Kobayashi S; Terayama N; Sanada J; Ueda K; Gabata T; Kadoya M; Miyayama S
Radiology; 2005 Nov; 237(2):512-9. PubMed ID: 16244260
[TBL] [Abstract][Full Text] [Related]
26. Small hepatic nodules in cirrhosis: ultrasonographic, CT, and MR imaging findings.
Kanematsu M; Hoshi H; Yamada T; Murakami T; Kim T; Kato M; Yokoyama R; Nakamura H
Abdom Imaging; 1999; 24(1):47-55. PubMed ID: 9933673
[TBL] [Abstract][Full Text] [Related]
27. Hepatocellular carcinoma: MR imaging findings in cirrhotic livers and noncirrhotic livers.
Winston CB; Schwartz LH; Fong Y; Blumgart LH; Panicek DM
Radiology; 1999 Jan; 210(1):75-9. PubMed ID: 9885590
[TBL] [Abstract][Full Text] [Related]
28. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
Lee MH; Kim SH; Park MJ; Park CK; Rhim H
AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
[TBL] [Abstract][Full Text] [Related]
29. Regenerating nodules of liver cirrhosis: MR imaging with pathologic correlation.
Ohtomo K; Itai Y; Ohtomo Y; Shiga J; Iio M
AJR Am J Roentgenol; 1990 Mar; 154(3):505-7. PubMed ID: 2154911
[TBL] [Abstract][Full Text] [Related]
30. Hepatocellular carcinoma with indeterminate or false-negative findings at initial MR imaging: effect on eligibility for curative treatment initial observations.
Choi D; Mitchell DG; Verma SK; Bergin D; Navarro VJ; Malliah AB; McGowan C; Hann HW; Herrine SK
Radiology; 2007 Sep; 244(3):776-83. PubMed ID: 17690322
[TBL] [Abstract][Full Text] [Related]
31. Expression of vascular endothelial growth factor in hepatocellular carcinoma and the surrounding liver and correlation with MRI findings.
Kanematsu M; Osada S; Amaoka N; Goshima S; Kondo H; Kato H; Nishibori H; Yokoyama R; Hoshi H; Moriyama N
AJR Am J Roentgenol; 2005 Mar; 184(3):832-41. PubMed ID: 15728605
[TBL] [Abstract][Full Text] [Related]
32. Small (<20 mm) enhancing hepatic nodules seen on arterial phase MR imaging of the cirrhotic liver: clinical implications.
Jeong YY; Mitchell DG; Kamishima T
AJR Am J Roentgenol; 2002 Jun; 178(6):1327-34. PubMed ID: 12034592
[TBL] [Abstract][Full Text] [Related]
33. Impact of diffusion-weighted MR imaging on the characterization of small hepatocellular carcinoma in the cirrhotic liver.
Le Moigne F; Durieux M; Bancel B; Boublay N; Boussel L; Ducerf C; Berthezène Y; Rode A
Magn Reson Imaging; 2012 Jun; 30(5):656-65. PubMed ID: 22459435
[TBL] [Abstract][Full Text] [Related]
34. Comparison of diffusion-weighted with T2-weighted Imaging for detection of small hepatocellular carcinoma in cirrhosis: preliminary quantitative study at 3-T.
Wang H; Wang XY; Jiang XX; Ye ZX
Acad Radiol; 2010 Feb; 17(2):239-43. PubMed ID: 19962912
[TBL] [Abstract][Full Text] [Related]
35. Regenerative nodules in hepatic cirrhosis. Value of gradient-echo MR imaging with a surface coil.
Van Beers B; Trigaux JP; Grandin C; Jamart J; Demeure R; Geubel A; Brenard R; Melange M; Dardenne AN; Pringot J
Acta Radiol; 1992 May; 33(3):245-50. PubMed ID: 1591127
[TBL] [Abstract][Full Text] [Related]
36. Infarcted regenerative nodules in cirrhosis: CT and MR imaging findings with pathologic correlation.
Kim T; Baron RL; Nalesnik MA
AJR Am J Roentgenol; 2000 Oct; 175(4):1121-5. PubMed ID: 11000176
[TBL] [Abstract][Full Text] [Related]
37. Hepatic malignancies: usefulness of acquisition of multiple arterial and portal venous phase images at dynamic gadolinium-enhanced MR imaging.
Peterson MS; Baron RL; Murakami T
Radiology; 1996 Nov; 201(2):337-45. PubMed ID: 8888220
[TBL] [Abstract][Full Text] [Related]
38. Hypovascular nodules in patients with chronic liver disease: risk factors for development of hypervascular hepatocellular carcinoma.
Hyodo T; Murakami T; Imai Y; Okada M; Hori M; Kagawa Y; Kogita S; Kumano S; Kudo M; Mochizuki T
Radiology; 2013 Feb; 266(2):480-90. PubMed ID: 23362095
[TBL] [Abstract][Full Text] [Related]
39. Hepatocellular carcinoma: MR imaging with mangafodipir trisodium (Mn-DPDP).
Murakami T; Baron RL; Peterson MS; Oliver JH; Davis PL; Confer SR; Federle MP
Radiology; 1996 Jul; 200(1):69-77. PubMed ID: 8657947
[TBL] [Abstract][Full Text] [Related]
40. Idiopathic hemochromatosis: MR imaging findings in cirrhotic and precirrhotic patients.
Siegelman ES; Mitchell DG; Outwater E; Munoz SJ; Rubin R
Radiology; 1993 Sep; 188(3):637-41. PubMed ID: 8351325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
